Diagnos Laboratorium Valuation
| DGNS Stock | IDR 210.00 6.00 2.78% |
At this time, the firm appears to be fairly valued. Diagnos Laboratorium shows a prevailing Real Value of 202.02 per share. The current price of the firm is 210.0. Our model computes the value of Diagnos Laboratorium from reviewing the firm fundamentals such as Operating Margin of 0.06 %, current valuation of 967.86 B, and Profit Margin of 0.06 % as well as analyzing its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Diagnos Laboratorium's price fluctuation is very steady at this time. Calculation of the real value of Diagnos Laboratorium is based on 3 months time horizon. Increasing Diagnos Laboratorium's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Diagnos Laboratorium's intrinsic value may or may not be the same as its current market price of 210.00, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 210.0 | Real 202.02 | Hype 210.0 |
The intrinsic value of Diagnos Laboratorium's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Diagnos Laboratorium's stock price.
Estimating the potential upside or downside of Diagnos Laboratorium Utama helps investors to forecast how Diagnos stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Diagnos Laboratorium more accurately as focusing exclusively on Diagnos Laboratorium's fundamentals will not take into account other important factors: Diagnos Laboratorium Total Value Analysis
Diagnos Laboratorium Utama is currently forecasted to have takeover price of 967.86 B with market capitalization of 302.5 B, debt of 10.45 B, and cash on hands of 52.8 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Diagnos Laboratorium fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
967.86 B | 302.5 B | 10.45 B | 52.8 B |
Diagnos Laboratorium Investor Information
About 80.0% of the company shares are held by company insiders. The company recorded earning per share (EPS) of 51.84. Diagnos Laboratorium last dividend was issued on the 6th of August 2021. Diagnos Laboratorium Utama is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.Diagnos Laboratorium Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Diagnos Laboratorium has an asset utilization ratio of 124.88 percent. This suggests that the Company is making 1.25 for each dollar of assets. An increasing asset utilization means that Diagnos Laboratorium Utama is more efficient with each dollar of assets it utilizes for everyday operations.Diagnos Laboratorium Ownership Allocation
Diagnos Laboratorium retains a total of 1.25 Billion outstanding shares. Diagnos Laboratorium Utama shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 80.0 percent of Diagnos Laboratorium outstanding shares that are owned by insiders denotes they have been buying or selling the stock in recent months in anticipation of some upcoming event. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.Diagnos Laboratorium Profitability Analysis
The company reported the revenue of 302.18 B. Net Income was 64.3 B with profit before overhead, payroll, taxes, and interest of 148.56 B.About Diagnos Laboratorium Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Diagnos Laboratorium Utama. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Diagnos Laboratorium based exclusively on its fundamental and basic technical indicators. By analyzing Diagnos Laboratorium's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Diagnos Laboratorium's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Diagnos Laboratorium. We calculate exposure to Diagnos Laboratorium's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Diagnos Laboratorium's related companies.PT Diagnos Laboratorium Utama Tbk provides health services using laboratories. The company was founded in 2007 and is headquartered in Jakarta Pusat, Indonesia. Diagnos Laboratorium operates under Diagnostics Research classification in Indonesia and is traded on Jakarta Stock Exchange. It employs 406 people.
8 Steps to conduct Diagnos Laboratorium's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Diagnos Laboratorium's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Diagnos Laboratorium's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Diagnos Laboratorium's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Diagnos Laboratorium's revenue streams: Identify Diagnos Laboratorium's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Diagnos Laboratorium's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Diagnos Laboratorium's growth potential: Evaluate Diagnos Laboratorium's management, business model, and growth potential.
- Determine Diagnos Laboratorium's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Diagnos Laboratorium's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Other Information on Investing in Diagnos Stock
Diagnos Laboratorium financial ratios help investors to determine whether Diagnos Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Diagnos with respect to the benefits of owning Diagnos Laboratorium security.